//
G. Kenet
Y.-C. Chen
G. Lowe
C. Percy
H. Tran
A. von Drygalski
M. Trossart
M. Reding
J. Oldenburg
M. Mingot Castellano
Y. S. Park
F. Peyvandi
J. Quinn
N. Mitchell
M. Huang
B. Kim
The National Hemophilia Center and Thrombosis Unit, and Amalia Biron Research Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer, Tel Aviv University, Tel Aviv, Israel
Hemophilia Care and Research Center, Tri‐Service General Hospital, Taipei, Taiwan
West Midlands Comprehensive Care Haemophilia Centre, Queen Elizabeth Hospital, Birmingham, United Kingdom
Haemostasis & Thrombosis Unit, Haemophilia Treatment Centre, The Alfred Hospital, Melbourne, Australia
Department of Molecular Medicine, Scripps Research Institute, La Jolla, United States
Centre régional de traitement de l'hémophilie, Chu de Nantes, Nantes, France
Center for Bleeding and Clotting Disorders, University of Minnesota, Minneapolis, Minnesota, United States
Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany
Regional University Hospital Carlos Haya, Malaga, Spain
Kyung Hee University Hospital at Gangdong, Seoul, Korea, Republic of
University of Milan, Milan, Italy
BioMarin Pharmaceutical Inc., Novato, United States
Israel
China
United Kingdom
Australia
United States
France
Germany
Spain
Republic of South Korea
Italy
N/A
Blood/haematological Diseases
Hemophilia
N/A
FVIII
N/A
Non Interventional
Multinational
Prospective
NA
N/A
N/A
N/A